Have a personal or library account? Click to login
Homozygous Pathogenic MYH3 Variants Associated With Arthrogryposis and Lingual Dystonia Cover

Homozygous Pathogenic MYH3 Variants Associated With Arthrogryposis and Lingual Dystonia

Open Access
|Oct 2025

References

  1. 1Albanese A, Bhatia KP, Fung VSC, Hallett M, Jankovic J, Klein C, et al. Definition and Classification of Dystonia. Movement Disorders [Internet]; 2025 [cited 2025 Jul 1]. Available from: https://pubmed.ncbi.nlm.nih.gov/40326714/.
  2. 2Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: Long-term follow-up. Neurology. 1999 Dec 10;53(9):21027. DOI: 10.1212/WNL.53.9.2102
  3. 3Blitzer A, Greene PE, Brin MF, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. Annals of Otology, Rhinology & Laryngology. 1989 Feb 1;98(2):937. DOI: 10.1177/000348948909800202
  4. 4Esper CD, Freeman A, Factor SA. Lingual protrusion dystonia: Frequency, etiology and botulinum toxin therapy. Parkinsonism Relat Disord. 2010 Aug 1;16(7):43841. DOI: 10.1016/j.parkreldis.2010.04.007
  5. 5Schneider SA, Aggarwal A, Bhatt M, Dupont E, Tisch S, Limousin P, et al. Severe tongue protrusion dystonia: Clinical syndromes and possible treatment. Neurology. 2006;67:9403. DOI: 10.1212/01.wnl.0000237446.06971.72
  6. 6Toydemir RM, Rutherford A, Whitby FG, Jorde LB, Carey JC, Bamshad MJ. Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome. Nat Genet. 2006 May;38(5):5615. DOI: 10.1038/ng1775
  7. 7Bamshad M, Van Heest AE, Pleasure D. Arthrogryposis: A review and update. In: Journal of Bone and Joint Surgery. Journal of Bone and Joint Surgery Inc.; 2009. pp. 406. DOI: 10.2106/JBJS.I.00281
  8. 8Chong JX, Burrage LC, Beck AE, Marvin CT, McMillin MJ, Shively KM, et al. Autosomal-dominant multiple pterygium syndrome is caused by mutations in MYH3. Am J Hum Genet. 2015 May 7;96(5):8419. DOI: 10.1016/j.ajhg.2015.04.004
  9. 9Cameron-Christie SR, Wells CF, Simon M, Wessels M, Tang CZN, Wei W, et al. Recessive Spondylocarpotarsal Synostosis Syndrome Due to Compound Heterozygosity for Variants in MYH3. Am J Hum Genet. 2018 Jun 7;102(6):111525. DOI: 10.1016/j.ajhg.2018.04.008
  10. 10Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine. 2015 May 8;17(5):40524. DOI: 10.1038/gim.2015.30
  11. 11Durkie M, Cassidy EJ, Berry I, Owens M, Turnbull C, Scott RH, et al. ACGS Best Practice Guidelines for Variant Classification in Rare Disease 2024. Royal Devon University Healthcare NHS Foundation Trust, Exeter, EX2 5DW 5 Division of Genetics and Epidemiology [Internet]. 2024 [cited 2024 Mar 20];12:157. Available from: http://gnomad.broadinstitute.org/.
  12. 12Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2023 Dec 6;625(7993):92100.
  13. 13Morali B, Miranda V, Raelson J, Grimard G, Glavas P, Audibert F, et al. Bi-allelic variants in MYH3 cause recessively-inherited arthrogryposis. Clin Genet [Internet]. 2024 Oct 1 [cited 2024 Dec 10];106(4):4837. Available from: https://pubmed.ncbi.nlm.nih.gov/38856159/. DOI: 10.1111/cge.14570
  14. 14Zhao S, Zhang Y, Hallgrimsdottir S, Zuo Y, Li X, Batkovskyte D, et al. Expanding the mutation and phenotype spectrum of MYH3-associated skeletal disorders. NPJ Genom Med. 2022 Dec 1;7(1):19. DOI: 10.1038/s41525-021-00273-x
  15. 15Carapito R, Goldenberg A, Paul N, Pichot A, David A, Hamel A, et al. Protein-altering MYH3 variants are associated with a spectrum of phenotypes extending to spondylocarpotarsal synostosis syndrome. European Journal of Human Genetics. 2016 Dec 1;24(12):174651. DOI: 10.1038/ejhg.2016.84
  16. 16Ledoux MS, Dauer WT, Warner TT. Emerging common molecular pathways for primary dystonia. Movement Disorders. NIH Public Access. 2013;28:96881. DOI: 10.1002/mds.25547
  17. 17Zhao S, Zhang Y, Hallgrimsdottir S, Zuo Y, Li X, Batkovskyte D, et al. Expanding the mutation and phenotype spectrum of MYH3-associated skeletal disorders. NPJ Genom Med [Internet]. 2022 Dec 1 [cited 2023 Nov 25];7(1):19. Available from: /pmc/articles/PMC8847563/. DOI: 10.1038/s41525-021-00273-x
  18. 18Koh YH, Rehfeld K, Ganetzky B. A Drosophila model of early onset torsion dystonia suggests impairment in TGF-β signaling. Hum Mol Genet [Internet]. 2004 Sep 15 [cited 2023 Dec 15];13(18):201930. Available from: https://pubmed.ncbi.nlm.nih.gov/15269177/. DOI: 10.1093/hmg/ddh208
  19. 19Saffari A, Lau T, Tajsharghi H, Karimiani EG, Kariminejad A, Efthymiou S, et al. The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders. Brain [Internet]. 2023 Aug 1 [cited 2025 May 3];146(8):327388. Available from: https://pubmed.ncbi.nlm.nih.gov/36757831/
  20. 20Yoshida K. Therapeutic strategies for oromandibular dystonia. Fortschritte der Neurologie Psychiatrie. 2021 Nov 1;89(11):56272. DOI: 10.1055/a-1375-0669
DOI: https://doi.org/10.5334/tohm.1079 | Journal eISSN: 2160-8288
Language: English
Submitted on: Jul 17, 2025
Accepted on: Oct 16, 2025
Published on: Oct 27, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Charlotte Mouraux, Claire Fouquet, Keith Durkin, Vinciane Dideberg, Saskia Bulk, David Aktan, Maria Artesi, Frédérique Depierreux, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.